An aspirin-free versus dual antiplatelet strategy for coronary stenting: STOPDAPT-3 randomized trial
M Natsuaki, H Watanabe, T Morimoto, K Yamamoto… - Circulation, 2024 - Am Heart Assoc
BACKGROUND: Bleeding rates on dual antiplatelet therapy (DAPT) within 1 month after
percutaneous coronary intervention (PCI) remain high in clinical practice, particularly in …
percutaneous coronary intervention (PCI) remain high in clinical practice, particularly in …
Bivalirudin versus unfractionated heparin in patients with myocardial infarction undergoing percutaneous coronary intervention: A systematic review and meta …
Background Bivalirudin is an alternative accepted therapy to unfractionated heparin for
patients with myocardial infarction (MI) undergoing percutaneous coronary intervention …
patients with myocardial infarction (MI) undergoing percutaneous coronary intervention …
Postprocedural Anticoagulation After Primary Percutaneous Coronary Intervention for ST-Segment–Elevation Myocardial Infarction: A Multicenter, Randomized …
Y Yan, J Guo, X Wang, G Wang, Z Fan, D Yin, Z Wang… - Circulation, 2024 - Am Heart Assoc
BACKGROUND: Postprocedural anticoagulation (PPA) is frequently administered after
primary percutaneous coronary intervention in ST-segment–elevation myocardial infarction …
primary percutaneous coronary intervention in ST-segment–elevation myocardial infarction …
Differential Use of Glycoprotein IIb/IIIa Inhibitors with Bivalirudin in Patients with STEMI Undergoing PCI: A Systematic Review and Meta-Analysis
H Mushahid, SA Shah, SH Farhan, MH Shuja… - American Journal of …, 2024 - Springer
Aim The efficacy and safety of bivalirudin when used concurrently with glycoprotein IIb/IIIa
inhibitors (GPI) is uncertain. In this systematic review and meta-analysis, we aimed to …
inhibitors (GPI) is uncertain. In this systematic review and meta-analysis, we aimed to …
Bivalirudin versus Heparin on net adverse clinical events, major adverse Cardiac and cerebral events, and bleeding in Elderly Chinese patients treated with …
Q Li, H Li, Z Liu, L Duan - The Tohoku Journal of Experimental …, 2024 - jstage.jst.go.jp
Bivalirudin as an anticoagulant reduces bleeding after percutaneous coronary intervention
(PCI), while its impact in elderly Chinese patients treated with PCI needs more evidence …
(PCI), while its impact in elderly Chinese patients treated with PCI needs more evidence …
Ticagrelor vs clopidogrel when coadministered with bivalirudin in patients with acute coronary syndrome undergoing percutaneous coronary intervention
Y Li, Y Li, M Qiu, Y Xue, K Xu, Y Han - Research and Practice in …, 2024 - Elsevier
Background The optimal perioperative antithrombotic strategy for patients with acute
coronary syndrome (ACS) during percutaneous coronary intervention (PCI) remains …
coronary syndrome (ACS) during percutaneous coronary intervention (PCI) remains …
[HTML][HTML] Effect of bivalirudin on myocardial microcirculation and adverse events after interventional therapy in older patients with acute coronary syndrome
YK Du, LJ Cui, HB Gao - World Journal of Clinical Cases, 2024 - wjgnet.com
BACKGROUND Bivalirudin, a direct thrombin inhibitor, is used in anticoagulation therapies
as a substitute for heparin, especially during cardiovascular procedures such as …
as a substitute for heparin, especially during cardiovascular procedures such as …
[PDF][PDF] Let us know how access to this document benefits yo u
B Brodie, B Gersh, T Stuckey, B Witzenbichler… - Cardiology - scholarlyworks.lvhn.org
When Is Door-to-Balloon Time Critical? Analysis From the HORIZONS-AMI (Harmonizing
Outcomes with Revascularization and Stents in Page 1 Lehigh Valley Health Network LVHN …
Outcomes with Revascularization and Stents in Page 1 Lehigh Valley Health Network LVHN …
[PDF][PDF] Average daily ischemic vs. bleeding risk in patients with ACS undergoing PCI: Insights from the Bleemacs and Renami Registries
IX Velicki, L Correia, E Cerrato, A Rognoni, U Fabrizio… - 2024 - iris.unito.it
Introduction. The risk of recurrent ischemia and bleeding after percutaneous coronary
intervention (PCI) for acute coronary syndrome (ACS) may vary during the firstyear of follow …
intervention (PCI) for acute coronary syndrome (ACS) may vary during the firstyear of follow …
[引用][C] Should Rotational Atherectomy be Used more Often in STEMI to Treat Calcified Culprit Lesions?
G Doolub, HQ Ly, G Marquis-Gravel - The Canadian Journal of …, 2024 - europepmc.org
Should Rotational Atherectomy be Used more Often in STEMI to Treat Calcified Culprit
Lesions? - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC …
Lesions? - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC …